Works matching IS 14611457 AND DT 2003 AND VI 6 AND IP 4

Results: 18

Changes in the IJNP Editorial Board.

Published in:

International Journal of Neuropsychopharmacology, 2003, v. 6, n. 4, p. 315, doi. 10.1017/s1461145703009908

By:

Bernard Lerer

Publication type:

Article

Opioid system in depression.

Published in:

International Journal of Neuropsychopharmacology, 2003, v. 6, n. 4, p. 443, doi. 10.1017/s1461145703003808

By:

Norbert Matussek

Publication type:

Article

The evidence-based pharmacological treatment of social anxiety disorder.

Published in:

International Journal of Neuropsychopharmacology, 2003, v. 6, n. 4, p. 427, doi. 10.1017/s1461145703003791

By:

Carlos Blanco;
Muhammad S. Raza;
Franklin R. Schneier;
Michael R. Liebowitz

Publication type:

Article

Evidence-based Psychopharmacology: Introduction to the Series.

Published in:

International Journal of Neuropsychopharmacology, 2003, v. 6, n. 4, p. 425, doi. 10.1017/s146114570300378x

By:

Dan J. Stein

Publication type:

Article

Possible relationship between mitochondrial DNA polymorphisms and lithium response in bipolar disorder.

Published in:

International Journal of Neuropsychopharmacology, 2003, v. 6, n. 4, p. 421, doi. 10.1017/s1461145703003778

By:

Shinsuke Washizuka;
Akifumi Ikeda;
Nobumasa Kato

Publication type:

Article

Nitric oxide involvement in depression during interferon-alpha therapy.

Published in:

International Journal of Neuropsychopharmacology, 2003, v. 6, n. 4, p. 415, doi. 10.1017/s1461145703003766

By:

Eiji Suzuki;
Yoshiko Yoshida;
Akitaka Shibuya;
Hitoshi Miyaoka

Publication type:

Article

Oxcarbazepine vs. valproate in the treatment of mood and schizoaffective disorders.

Published in:

International Journal of Neuropsychopharmacology, 2003, v. 6, n. 4, p. 409, doi. 10.1017/s1461145703003754

By:

Michele Raja;
Antonella Azzoni

Publication type:

Article

Minimum effective doses of haloperidol for the treatment of first psychotic episode: a comparative study with risperidone and olanzapine.

Published in:

International Journal of Neuropsychopharmacology, 2003, v. 6, n. 4, p. 403, doi. 10.1017/s1461145703003742

By:

Rogelio Apiquian;
Ana Fresán;
Karen Herrera;
Rosa Elena Ulloa;
Cristina Lóyzaga;
Camilo de la Fuente-Sandoval;
Doris Gutiérrez;
Humberto Nicolini

Publication type:

Article

Risperidone augmentation in treatment-resistant obsessivecompulsive disorder: a double-blind, placebo-controlled study.

Published in:

International Journal of Neuropsychopharmacology, 2003, v. 6, n. 4, p. 397, doi. 10.1017/s1461145703003730

By:

Eric Hollander;
Nicolò Baldini Rossi;
Erica Sood

Publication type:

Article

Desipramine treatment reduces the long-term behavioural and neurochemical sequelae of early-life maternal separation.

Published in:

International Journal of Neuropsychopharmacology, 2003, v. 6, n. 4, p. 391, doi. 10.1017/s1461145703003729

By:

Glenda M. MacQueen;
Karuna Ramakrishnan;
Ravena Ratnasingan;
Biao Chen;
L. Trevor Young

Publication type:

Article

Mechanisms of altered Ca2+ signalling in transformed lymphoblastoid cells from patients with bipolar disorder.

Published in:

International Journal of Neuropsychopharmacology, 2003, v. 6, n. 4, p. 379, doi. 10.1017/s1461145703003717

By:

Tadafumi Kato;
Mizuho Ishiwata;
Kanako Mori;
Shinsuke Washizuka;
Osamu Tajima;
Tsuyoshi Akiyama;
Nobumasa Kato

Publication type:

Article

Motor-evoked potential amplitudes elicited by transcranial magnetic stimulation do not differentiate between patients and normal controls.

Published in:

International Journal of Neuropsychopharmacology, 2003, v. 6, n. 4, p. 371, doi. 10.1017/s1461145703003705

By:

Leon Grunhaus;
Dana Polak;
Revital Amiaz

Publication type:

Article

Decreased thalamic D2/D3 receptor binding in drug-naive patients with schizophrenia: a PET study with [11C]FLB 457.

Published in:

International Journal of Neuropsychopharmacology, 2003, v. 6, n. 4, p. 361, doi. 10.1017/s1461145703003699

By:

Mirjam Talvik;
Anna-Lena Nordström;
Hans Olsson;
Christer Halldin;
Lars Farde

Publication type:

Article

Drug-induced parkinsonism in relation to choline-containing compounds measured by 1H-MR spectroscopy in putamen of chronically medicated patients with schizophrenia.

Published in:

International Journal of Neuropsychopharmacology, 2003, v. 6, n. 4, p. 353, doi. 10.1017/s1461145703003687

By:

Hidenori Yamasue;
Tsunehiro Fukui;
Rin Fukuda;
Kiyoto Kasai;
Akira Iwanami;
Nobumasa Kato;
Tadafumi Kato

Publication type:

Article

Psychotic symptoms in methamphetamine psychotic in-patients.

Published in:

International Journal of Neuropsychopharmacology, 2003, v. 6, n. 4, p. 347, doi. 10.1017/s1461145703003675

By:

Manit Srisurapanont;
Robert Ali;
John Marsden;
Agueda Sunga;
Kiyoshi Wada;
Maristela Monteiro

Publication type:

Article

Age-dependent antidepressant pharmacogenomics: polymorphisms of the serotonin transporter and G protein β3 subunit as predictors of response to fluoxetine and nortriptyline.

Published in:

International Journal of Neuropsychopharmacology, 2003, v. 6, n. 4, p. 339, doi. 10.1017/s1461145703003663

By:

Peter R. Joyce;
Roger T. Mulder;
Suzanne E. Luty;
Janice M. McKenzie;
Allison L. Miller;
Geraldine R. Rogers;
Martin A. Kennedy

Publication type:

Article

Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia.

Published in:

International Journal of Neuropsychopharmacology, 2003, v. 6, n. 4, p. 325, doi. 10.1017/s1461145703003651

By:

Siegfried Kasper;
Mark N. Lerman;
Robert D. McQuade;
Anutosh Saha;
William H. Carson;
Mirza Ali;
Donald Archibald;
Gary Ingenito;
Ronald Marcus;
Teresa Pigott

Publication type:

Article

Fluvoxamine CR in the long-term treatment of social anxiety disorder: the 12- to 24-week extension phase of a multicentre, randomized, placebo-controlled trial.

Published in:

International Journal of Neuropsychopharmacology, 2003, v. 6, n. 4, p. 317, doi. 10.1017/s146114570300364x

By:

Dan J. Stein;
Herman G. M. Westenberg;
Haichen Yang;
David Li;
Luigi M. Barbato

Publication type:

Article

Works matching IS 14611457 AND DT 2003 AND VI 6 AND IP 4

Changes in the IJNP Editorial Board.

Opioid system in depression.

The evidence-based pharmacological treatment of social anxiety disorder.

Evidence-based Psychopharmacology: Introduction to the Series.

Possible relationship between mitochondrial DNA polymorphisms and lithium response in bipolar disorder.

Nitric oxide involvement in depression during interferon-alpha therapy.

Oxcarbazepine vs. valproate in the treatment of mood and schizoaffective disorders.

Minimum effective doses of haloperidol for the treatment of first psychotic episode: a comparative study with risperidone and olanzapine.

Risperidone augmentation in treatment-resistant obsessivecompulsive disorder: a double-blind, placebo-controlled study.

Desipramine treatment reduces the long-term behavioural and neurochemical sequelae of early-life maternal separation.

Mechanisms of altered Ca<sup>2+</sup> signalling in transformed lymphoblastoid cells from patients with bipolar disorder.

Motor-evoked potential amplitudes elicited by transcranial magnetic stimulation do not differentiate between patients and normal controls.

Decreased thalamic D<sub>2</sub>/D<sub>3</sub> receptor binding in drug-naive patients with schizophrenia: a PET study with [<sup>11</sup>C]FLB 457.

Drug-induced parkinsonism in relation to choline-containing compounds measured by <sup>1</sup>H-MR spectroscopy in putamen of chronically medicated patients with schizophrenia.

Psychotic symptoms in methamphetamine psychotic in-patients.

Age-dependent antidepressant pharmacogenomics: polymorphisms of the serotonin transporter and G protein β3 subunit as predictors of response to fluoxetine and nortriptyline.

Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia.

Fluvoxamine CR in the long-term treatment of social anxiety disorder: the 12- to 24-week extension phase of a multicentre, randomized, placebo-controlled trial.